Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor. Read more about Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor.
Principles and current strategies for targeting autophagy for cancer treatment. Read more about Principles and current strategies for targeting autophagy for cancer treatment.
Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas. Read more about Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas.
Response to combined molecular targeting: defining the role of P-STAT3. Read more about Response to combined molecular targeting: defining the role of P-STAT3.
Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutations. Read more about Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutations.
Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer. Read more about Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer.
Antitumor activity of SNX-2112, a synthetic heat shock protein-90 inhibitor, in MET-amplified tumor cells with or without resistance to selective MET Inhibition. Read more about Antitumor activity of SNX-2112, a synthetic heat shock protein-90 inhibitor, in MET-amplified tumor cells with or without resistance to selective MET Inhibition.
Evaluation of the anti-HER2 C6.5 diabody as a PET radiotracer to monitor HER2 status and predict response to trastuzumab treatment. Read more about Evaluation of the anti-HER2 C6.5 diabody as a PET radiotracer to monitor HER2 status and predict response to trastuzumab treatment.
Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. Read more about Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Blinded by the light: molecular imaging in pancreatic adenocarcinoma. Read more about Blinded by the light: molecular imaging in pancreatic adenocarcinoma.
